FibroBiologics, Inc. Common Stock (FBLG) — Financial Flexibility Index
FibroBiologics, Inc. Common Stock (FBLG) has a Financial Flexibility Index of -0.46x as of September 2025. Free cash flow of $-3.97 Million (operating CF $-3.97 Million minus capex $6.00K) represents 0% of total liabilities ($8.62 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
FibroBiologics, Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for FibroBiologics, Inc. Common Stock across 4 annual periods. See working capital position of FibroBiologics, Inc. Common Stock to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for FibroBiologics, Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for FibroBiologics, Inc. Common Stock. For the full company profile including market capitalisation, see FBLG stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.85x | $-11.72 Million | $-11.90 Million | $13.71 Million | ▼ -52.9% |
| 2024 | -0.56x | $-5.91 Million | $-6.40 Million | $10.57 Million | ▼ -21.2% |
| 2023 | -0.46x | $-4.07 Million | $-4.07 Million | $8.82 Million | ▲ +42.5% |
| 2022 | -0.80x | $-1.41 Million | $-1.41 Million | $1.76 Million | — |